PALLADINI, GIUSEPPINA
 Distribuzione geografica
Continente #
NA - Nord America 1.418
EU - Europa 957
AS - Asia 537
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.917
Nazione #
US - Stati Uniti d'America 1.413
CN - Cina 528
IE - Irlanda 375
UA - Ucraina 151
FI - Finlandia 138
DE - Germania 99
IT - Italia 67
GB - Regno Unito 39
SE - Svezia 37
BE - Belgio 21
FR - Francia 21
CA - Canada 5
RU - Federazione Russa 4
CZ - Repubblica Ceca 3
KR - Corea 3
EG - Egitto 2
IN - India 2
NL - Olanda 2
AU - Australia 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SG - Singapore 1
Totale 2.917
Città #
Chandler 399
Dublin 375
Jacksonville 193
Nanjing 141
Ashburn 75
Beijing 75
Ann Arbor 74
Nanchang 68
Lawrence 59
Princeton 59
Medford 58
Helsinki 57
Hebei 50
New York 47
Wilmington 45
Shenyang 43
Changsha 37
Shanghai 33
Pavia 26
Boardman 25
Milan 24
Brussels 21
Jiaxing 21
Hangzhou 19
Tianjin 19
Norwalk 11
Woodbridge 10
Verona 8
Auburn Hills 7
Des Moines 7
Berlin 6
Houston 6
Fairfield 4
Falls Church 4
Toronto 4
Washington 4
Brno 3
Los Angeles 3
Ningbo 3
Orange 3
Saint Petersburg 3
Seattle 3
Taizhou 3
Alexandria 2
Changchun 2
Fuzhou 2
Kouvola 2
Menlo Park 2
Munich 2
Redwood City 2
Rockville 2
Seoul 2
Auckland 1
Cesena 1
Clearwater 1
General Trias 1
Giussano 1
Guangzhou 1
Gunzenhausen 1
Jinan 1
Kemerovo 1
Kunming 1
Laurel 1
Milton Keynes 1
Philadelphia 1
Qingdao 1
San Francisco 1
Schenectady 1
Seveso 1
Singapore 1
Sydney 1
Tangjin 1
Zhengzhou 1
Totale 2.174
Nome #
Effect of chronic sympatectomy in a model of rat cardiac hypertrophy: role of the extracellular matrix. 78
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. 76
Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure. 76
Remote matrix metalloproteinases activation as systemic consequence pf liver injury: the role of lung. 76
Cardiac mast cells in the transition to heart failure: innocent bystanders or key actors? 75
Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers. 74
Interstitial fibrosis is blunted by chronic sympathectomy in experimental pressure-overload hypertrophy. 73
Effetti del desametasone sulla tossicità da cadmio in epatociti in coltura 71
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis 68
Adenosine A1 and A2A receptor cross-talk during ageing in the rat myocardium 67
Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure 66
Effects of the chronic digoxin administration on extracellular matrix turnover in a model of cardiac hypertrophy in Guinea pigs. 65
A nuclear pool of glutathione in hepatocytes 63
Video "imaging" metabolico: applicazioni in tossicologia sperimentale 62
Cardiovascular modulation and postural hypotension in primary amyloidosis 62
EFFECTS OF GLUCAGON AND DEXAMETHASONE ON CADMIUM TOXICITY IN RAT HEPATOCYTES IN PRIMARY MONOLAYER CULTURE 61
Matrix metalloproteinases: analysis of the activity in Guinea pig cardiac hypertrophy. 59
Nuclear glutathione: regulation and physiological and toxicological significance 59
Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers 58
Metalloproteasi di matrice e progressiva disfunzione diastolica del cuore ipertrofico. 57
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy 57
Lung Matrix Metalloproteinase Activation following Partial Hepatic Ischemia/Reperfusion Injury in Rats 57
Cytoskeletal modifications of human mammary adenocarcinoma cells caused by TNF-alpha 57
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. 56
Nuclear glutathione: a search for functions 55
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 52
Effects of a Bioavailable Arabinoxylan-enriched White Bread Flour on Postprandial Glucose Response in Normoglycemic Subjects 52
Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy 51
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 49
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 49
Evaluation of matrix metalloproteases activity in Guinea pig cardiac hypertrophy. 48
USE OF DIGITIZED FLUORESCENCE VIDEO MICROSCOPY TO INVESTIGATE THIOL-INDUCED CHANGES IN CHROMATIN CONFORMATION 47
Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis 45
CYTOSKELETAL MODIFICATION OF HUMAN MAMMARY ADENOCARCINOMA CELLS CAUSED BY TNF-ALPHA 44
iNVESTIGATIONS ON GLUTATHIONE DISTRIBUTION AND GLUTATHIONE-CONJUGATE FORMATION AND FATE IN ISOLATED HEPATOCYTES USING DIGITIZED FLUORESCENCE VIDEO MICROSCOPY 43
Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension? 43
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 40
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 40
Histochemical study of cardiac mast cells degranulation and collagen deposition : interaction with the cathecolaminergic system in the rat 39
A multimarker study of degenerative aortic valve disease: Stenoinsufficiency shows more indices of bad prognosis 38
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 37
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 36
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 36
Modulation of chromatin conformation in hepatocyte nuclei by thiol oxidation and reduction 35
null 35
Intranuclear distribution, function and fate of glutathione and glutathione-S-conjugate in living rat hepatocytes studied by fluorescence microscopy 35
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 34
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 32
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 32
Use of digitized fluorescence video microscopy to investigate thiol-induced changes in chromatin conformation 31
Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy 29
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 29
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 28
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 28
Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review 25
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 25
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 24
Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis 23
Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis 22
Obeticholic acid reduces hepatic matrix metalloproteinase activity in a diet-induced ob/ob mouse model of NASH 19
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 17
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 15
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH 13
Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion 12
MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis 9
Totale 2.969
Categoria #
all - tutte 10.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.071


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 2 0 6
2019/2020622 172 227 12 28 0 35 7 29 3 54 53 2
2020/2021283 32 23 7 29 0 36 10 45 18 43 35 5
2021/2022259 7 3 2 6 5 6 6 20 7 6 54 137
2022/20231.104 126 71 31 101 83 112 0 74 456 8 34 8
2023/2024338 58 55 14 22 42 95 23 19 3 7 0 0
Totale 2.969